Object Although radiosurgery has been well accepted as a treatment for small- to medium-sized vestibular schwannomas (VSs), its application in the treatment of large VSs remains controversial because of unfavorable effects such as tumor swelling and potential compression of the brainstem. The authors present a retrospective study spanning 17 years, during which 21 patients underwent Gamma Knife surgery (GKS) for large VSs. Long-term outcomes are reported, and possible factors affecting tumor responses to GKS are analyzed. Methods Five hundred thirteen patients harboring VSs underwent GKS between March 1993 and October 2009. A large VS was defined as a tumor whose diameter was > 3 cm. This paper focuses on 21 patients who harbored large VSs ranging in volume from 12.7 to 25.2 cm3 (mean 17.3 cm3) and were treated by GKS. Fourteen of these patients had undergone 1 or more craniotomies previously to remove the tumor. Seven patients underwent GKS alone because of patient preference or a poor clinical condition that precluded microsurgery with general anesthesia. The mean radiation dose directed to the tumor ranged from 15 to 17.5 Gy. The mean radiation dose prescribed to the tumor margin was 11.9 Gy (range 11–14 Gy). The mean follow-up period was 66 months (range 12–155 months), and the median follow-up period was 53 months. Results The tumor control rate was 90.5% (19 of 21 lesions). No deterioration in facial nerve or trigeminal nerve function was noted. Disturbances in balance (some temporary) occurred in 5 patients. Three of the 21 patients developed initial tumor swelling, which required minor surgical interventions, including aspiration using an Ommaya reservoir or placement of a ventriculoperitoneal shunt. All 3 patients recovered satisfactorily after aspiration of an enlarging cyst or ventriculoperitoneal shunt placement. There was no significant correlation between tumor control and the following factors: patient age or sex, tumor volume, radiation dose, previous operation, presence of brainstem compression, petrous bone invasion, T2 signal ratio between tumor and brainstem, and presence of a cyst. However, there was a significant correlation between the T2 signal ratio between tumor and brainstem and the duration of tumor swelling (p = 0.003). Conclusions Treatment of large VSs remains a challenge to neurosurgeons regardless of whether they perform microsurgery or radiosurgery. Control of tumor growth and preservation of neurological function are the main goals of treatment. Although delayed microsurgery was required in 2 patients (9.5%), the satisfactory tumor control rate and excellent preservation of facial and trigeminal nerve function are the great advantages of radiosurgery. Radiosurgery is not only a practical treatment for patients with small- to medium-sized VSs, but it is also an excellent tool for treating larger tumors up to 25 cm3. In selected cases, radiosurgery plays an important role in treating large VSs with satisfactory results.
Compared with the standard transoral approach, the transnasal transclival endoscopic approach for decompressing basilar invagination is a feasible and effective alternative that avoids common disadvantages like prolonged intubation, excessive tongue retraction, and the need for palatal incision.
We evaluated the predictive value of O6-methylguanine-DNA methyltransferase (MGMT) protein expression and MGMT promoter methylation status in glioblastomas (GBM) treated with temozolomide (TMZ) in a Taiwan medical center. Protein expression by immunohistochemical analysis (IHC) and MGMT promoter methylation detected by methylation-specific polymerase chain reaction (MSP) were performed in a series of 107 newly diagnosed GBMs. We used endothelial cells as an internal reference for IHC staining because the staining intensities of the MGMT-expressing cells in different specimens varied considerably; a positive result was defined as the staining intensity of the majority of tumor cells similar to that of the adjacent endothelial cells. Immunostainings for microglial/endothelial markers were included as part of the MGMT IHC evaluation, and in cases that were difficult to interpret, double-labeling helped to clarify the nature of reactive cells. The MGMT protein expression was reversely associated with MGMT promoter methylation status in 83.7% of cases (MSP/IHC and MSP/IHC; Pearson r=-0.644, P<0.001). Twenty-two of 24 (91.7%) IHC tumors did not respond to TMZ treatment. Combining MSP and IHC results, all the 15 MSP/IHC GBMs were TMZ resistant. The MGMT status detected by either IHC or MSP was significantly correlated with the TMZ treatment response (both P<0.001) and survival of GBM patients (both P<0.05).
Stereotactic radiosurgery for vestibular schwannomas (VSs) has become popular during the last decade with promising clinical results after long-term follow-up. However, on rare occasions, some cases have needed traditional microsurgery to remove the tumor several months or years after radiosurgery. We present a retrospective analysis of data acquired during a 16-year period in delayed microsurgery of seven patients with VSs who underwent gamma knife surgery (GKS). A total of 444 with VS underwent GKS between March 1993 and December 2008, and 7 (1.57%) underwent delayed microsurgery at a median of 26 months (range from 3 months to 6 years) after GKS. The mean size of the tumor during GKS was 10.4 ml (range 2.3-23.5 ml). These seven patients were younger, and female predominant. The indications of microsurgery included adverse radiation effect with peri-focal edema, tumor enlargement, and cyst enlargement. Although the perifocal edema could lead to more difficulty in surgery than in typically performed operations for schwannoma, subtotal resection was achieved in all patients. There was no surgery-related morbidity or mortality. The histology showed benign tumor in five patients, malignant peripheral nerve sheath tumor in one, and necrotic tissue in one. The need of microsurgery for further treatment of VS after radiosurgery is rare, but can be a challenge to neurosurgeons in terms of surgical indication, timing, and techniques. The authors concluded the incidence of delayed microsurgery was 1.57% in a series of 444 patients over a 16-year period. We concluded some experience from operative indications, timing, approach, and outcome.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.